Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Tralokinumab for Atopic Hand Eczema
Recruiting1 awardPhase 3
Detroit, Michigan
This trial tests if tralokinumab is safe & effective to treat atopic hand eczema. Participants will get injections every 2 weeks up to 40 weeks, with 3 phone visits.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.